Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors.

MLA

Tao, Zhi-Fu, et al. “Structure-Based Design, Synthesis, and Biological Evaluation of Potent and Selective Macrocyclic Checkpoint Kinase 1 Inhibitors.” Journal of Medicinal Chemistry, vol. 50, no. 7, Apr. 2007, pp. 1514–27. EBSCOhost, https://doi.org/10.1021/jm061247v.

APA

Tao, Z.-F., Wang, L., Stewart, K. D., Chen, Z., Gu, W., Bui, M.-H., Merta, P., Zhang, H., Kovar, P., Johnson, E., Park, C., Judge, R., Rosenberg, S., Sowin, T., & Lin, N.-H. (2007). Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors. Journal of Medicinal Chemistry, 50(7), 1514–1527. https://doi.org/10.1021/jm061247v

Chicago

Tao, Zhi-Fu, Le Wang, Kent D Stewart, Zehan Chen, Wendy Gu, Mai-Ha Bui, Philip Merta, et al. 2007. “Structure-Based Design, Synthesis, and Biological Evaluation of Potent and Selective Macrocyclic Checkpoint Kinase 1 Inhibitors.” Journal of Medicinal Chemistry 50 (7): 1514–27. doi:10.1021/jm061247v.